PROGRAM

First European Course on Diagnosis and Management of RLS


Morning Session:

Chairpersons: Yves Dauvilliers and Mauro Manconi

20-minute lectures followed by 10 minutes discussion with the audience

08:45          Welcome and Introduction
                   Birgit Högl (EURLSSG President), Innsbruck, Austria

09:00          Diagnostic clues to RLS
                   Birgit Högl, Innsbruck, Austria

09:30          RLS pathophysiology and genetics in a nutshell
                   Barbara Schormair, Munich, Germany

10:00          RLS mimics and differential diagnosis
                   Birgit Högl, Innsbruck, Austria

10:30          Which laboratory and other exams do I need to diagnose RLS?
                   Diego Garcia-Borreguero, Madrid, Spain

11:00          RLS and comorbidity why is it no longer symptomatic RLS?
                   Klaus Berger, Muenster, Germany

11:30          The patient´s perspective
                   Joke Jaarsma & Diego Garcia-Borreguero

 

12:00 Interactive Lunch Session

An opportunity for participants to discuss difficult cases with an expert


 

First afternoon Session: Treating RLS

Chairpersons: Diego Garcia-Borreguero and Klaus Berger

13:00          What is augmentation, and how do you recognize it in time?
                   Mauro Manconi, Lugano, Switzerland

13:20          Are dopaminergic agents are still first line? How should they be used?
                   Yves Dauvilliers, Montpellier, France

13:40          What is the role of alpha-2-delta ligands? When should they be initiated?
                   Diego Garcia-Borreguero, Madrid, Spain

14:00          Discussion: Moderator Mauro Manconi

 

Each of the following 20-minute lectures is followed by 10 minutes discussion with the audience.

14:30          Opioids in RLS: when and how?
                   Roselyne Rijsman, The Hague, The Netherlands

15:00          Iron for all RLS? What is the role of oral and intravenous iron?
                   Rosalia Silvestri, Messina, Italy

15:15          Dealing with augmentation
                   Diego Garcia-Borreguero, Madrid, Spain

 

15:45  Coffee break and networking

 

Second Afternoon Session: Treatment Issues in comorbid RLS

Chairpersons: Roselyne Rijsman and Barbara Schormair

Short, 12-minute patient-based interactive lectures followed by discussion with the audience at the end of the session

16:15          RLS in pregnancy
                   Mauro Manconi, Lugano, Switzerland

16:27          RLS in children
                   Rosalia Silvestri, Messina, Italy

16:39          RLS in depression
                   Rosalia Silvestri, Messina, Italy

16:51          RLS in Parkinson´s disease
                   Roselyne Rijsman, The Hague, The Netherlands

17:03          RLS in end-stage renal disease (ESRD)
                   Georgios Hadjigeorgiou, Larissa, Greece

17:15          Cardiovascular / RLS in multi-morbi patients
                   Yves Davilliers, Montpellier, France

17:39          Q&A Session and closing remarks
                   Birgit Högl (EURLSSG President), Innsbruck, Austria

18:00          Close